Overall, our studies demonstrate that: (1) at 4 months of age (pre-pathology stage), the expression levels of the EGR2 and histone 1H2AA genes were altered in female TG-AD rats, suggesting that they could be early biomarkers for women with AD. This evidence concerns the gene EGR2 and Alzheimer disease.